Merck to Build EUR 300-Million Research Center
The pharmaceuticals and chemicals giant is investing a hefty nine-figure in a state-of-the-art facility in its home city of Darmstadt.
Your company is already operating in Germany and you would now like to export worldwide?
The pharmaceuticals and chemicals giant is investing a hefty nine-figure in a state-of-the-art facility in its home city of Darmstadt.
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
Germany is undertaking a “digital revolution” in healthcare and now has a strategy to make life easier for pharmaceutical companies.
American pharmaceutical company Lilly will construct a USD 2.5 billion high-tech production site in Alzey in the west of Europe’s largest healthcare market.
MEDICA 2023, the world-leading information and communication platform for the medical technology industry and supplier industry took place in November.
Innovative start-ups are booming in Germany's attractive life sciences sector.
Therapeutics and autonomous driving, recycling and space junk, are all part of our regular survey of some of the most interesting developments in German research and development.
Japanese pharmaceuticals giant Takeda has put hundreds of millions of euros in recent years into its location in the southwestern German town of Singen to produce its anti-dengue-fever vaccine “Qdenga.”